DIG
ICPT

DeepCurrents Investment Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

DeepCurrents Investment Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,994
Closed -$231K – 266
2021
Q1 		$231K Buy
+9,994
New +$279K 0.01% 171
2020
Q1 		– Sell
-2,600
Closed -$234K – 139
2019
Q4 		$322K Buy
+2,600
New +$233K 0.01% 108

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

DeepCurrents Investment Group's ICPT Position: Q2 2021 in Review

DeepCurrents Investment Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 9,994 shares — an estimated $231K sold.

DeepCurrents Investment Group first reported a position in ICPT in Q4 2019 and held it in 2 quarters. The position peaked at $322K in Q4 2019. 129 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

  • DeepCurrents Investment Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • DeepCurrents Investment Group sold 9,994 Intercept Pharmaceuticals, Inc. shares in Q2 2021, an estimated $231K.
  • DeepCurrents Investment Group first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2019 and held it in 2 quarters.
  • DeepCurrents Investment Group's Intercept Pharmaceuticals, Inc. position peaked at $322K in Q4 2019.
  • 129 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on DeepCurrents Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.